The latest from DTC Perspectives
Tauzin, PhRMA, and Pepsi
Friday, 18 July 2008, 07:47 AM
In a Wall Street Journal blog by Alicia Mundy (July 15), Billy Tauzin, head of PhRMA was quoted saying, “Our members were advertising life-saving medicines like it‘s Pepsi and that hurt us.” Tauzin was referring to all the flak from Congress recently leading to new promotional guidelines on gifts to physicians, as well as the 6 month voluntary DTC advertising moratorium on new products agreed to by several companies. read more
Announcing DTC-TV by DTC Perspectives
Wednesday, 16 July 2008, 02:11 PM
DTC Perspectives, Inc. is pleased to announce the launch of its new on-demand online video forum, DTC-TV. Consisting of periodic interviews with DTC thought leaders, DTC-TV is designed to provide busy DTC marketers with an easy access portal for hearing insights. Visitors are able to discover ideas on the key DTC issues from both within pharma and from outside experts on such areas as regulatory and legislative matters, marketing and media trends. Each interview is concise, usually with a running time of 12 to 20 minutes. read more
Guest Commentary - Has DTC Reached the Point of Diminishing Returns?
Tuesday, 15 July 2008, 03:22 PM
There's no question that mass advertising produces a significant increase in sales for pharmaceutical brands. But the return on investment in DTC advertising has remained, on average, a paltry 2:1 and has not improved much in recent years. read more
West Virginia report shows $16 million in DTC ad spending
Friday, 11 July 2008, 04:11 PM
According to a report this week from a West Virginia state agency, drug companies spent more than $16 million on consumer advertising in the state between July-December 2007. The state’s Pharmaceutical Cost Management Council issued the spending breakdown July 7. read more
Age Appropriate DTC
Friday, 11 July 2008, 08:34 AM
In PhRMA Guiding Principle 13, it says “DTC television and print should be targeted to avoid audiences that are not age appropriate for the messages involved.” Sounds clear, but is it really? Erectile dysfunction (ED) drugs are being criticized for advertising on daytime sports. In fact, the president elect of the American Medical Association testified at the recent Stupak-Dingell hearings how embarrassed she was that young children were seeing these ads. read more
Blogspectives - Issue 3
Tuesday, 08 July 2008, 01:44 PM
In our third issue of Blogspectives, I have commented on recent health blog posts discussing pharmaceutical marketing, public policy, and consumer trends and behavior. This is not a blog recap per se, but my editorial spin, comment, rebuttal or agreement with those bloggers. read more
Group Says Pharma Companies Have Spent Over $1 billion in Federal Lobbying over Past Decade
Thursday, 03 July 2008, 03:08 PM
The Center for Public Integrity, using information from the Senate Office of Public Records, announced that the pharmaceutical industry spent $168 million on lobbyists in 2007, a 32 percent jump over 2006. When added together with medical device and other health product manufacturer lobbyist spending, the total increases to $189 million, a threefold increase when compared to the $67 million spent in 1998 (the first complete year where records were available. The group says that pharma has spent more than $1 billion on lobbying in the past read more
Vytorin to the Supermarket Aisle
Tuesday, 01 July 2008, 04:18 PM
According to the Star-Ledger newspaper of Newark, N.J., a Super Stop & Shop supermarket outside of New Brunswick last week featured a display and dispenser with fold-up ads for the prescription medicine Vytorin in the health-care aisle, where the store sells pain-relievers, allergy pills and aspirin. Advertising of this type is not uncommon in the pharmaceutical world, particularly in drugstores, but is customarily used for over-the-counter drugs and remedies. read more
Device Makers Step Up Marketing Efforts
Monday, 30 June 2008, 02:19 PM
The following is an edited transcript of a round-table interview conducted by the online magazine Medical Device Link (www.DeviceLink.com). It was moderated by Lori Luechtefeld. The consensus view among the marketers and agency executives who participated in the round-table discussion is that medical device market¬ers today are harnessing novel approaches and cutting-edge tools to facilitate communication with their audiences.
read more
Industry Reputation Declines Again
Friday, 27 June 2008, 08:25 AM
For those employed by the pharmaceutical industry that feel they must defend their company/industry to their friends, neighbors and relatives, the news is bad. A recent survey just released by Harris Interactive shows the pharmaceutical industry has lost ground in 2007 versus the prior year. Positive ratings declined another 2 points in 2007 to a low of 26% of American consumers who give drug companies a positive rating. read more
  1 2 3 [4] 5 6 7 8   |
| Total: 74 |
DTC and You
DTC in the Era of Consumer Choice
Register Now for this year's Fall Conference, focusing
on how DTC marketing must change in the face
of ever-increasing consumer pressures.
FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
DTC Perspectives Magazine is published quarterly.
Subscribe to DTC Insights
The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.
Subscribe to Bob Ehrlich’s newsletter
A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.
| ABOUT SSL CERTIFICATES |
